Monitoring warfarin therapy.
Beanland
D R
DR
Dorsey
D A
DA
D000925:Anticoagulants / Q000009:adverse effects*; D004844:Epistaxis / Q000139:chemically induced*; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D014812:Vitamin K / Q000627:therapeutic use; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin